Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update

Neurology. 2021 Aug 3;97(5):239-245. doi: 10.1212/WNL.0000000000012198.
No abstract available

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Evidence-Based Medicine
  • Humans
  • Insurance, Health
  • Mental Disorders / etiology
  • Neurology / trends*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy
  • Parkinson Disease / therapy*
  • Quality Improvement*
  • Quality of Health Care
  • Rehabilitation / methods
  • Sleep Wake Disorders / etiology
  • Sleep Wake Disorders / therapy

Substances

  • Antiparkinson Agents